SIRT2 and Alzheimer disease: Furthermore, SIRT2 mRNA levels increased in the peripheral blood of patients with AD (Wongchitrat et al., 2019), and SIRT2 levels escalated alongside the decreased acetylation of its recognized substrate α‐tubulin in the AD brain (Silva, Esteves, Oliveira, & Cardoso, 2016).